A detailed history of Vanguard Group Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 40,226,214 shares of MRNA stock, worth $1.65 Billion. This represents 0.05% of its overall portfolio holdings.

Number of Shares
40,226,214
Previous 39,562,796 1.68%
Holding current value
$1.65 Billion
Previous $4.7 Billion 42.78%
% of portfolio
0.05%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$63.64 - $125.14 $42.2 Million - $83 Million
663,418 Added 1.68%
40,226,214 $2.69 Billion
Q2 2024

Aug 13, 2024

BUY
$101.21 - $166.61 $53.2 Million - $87.6 Million
525,924 Added 1.35%
39,562,796 $4.7 Billion
Q1 2024

May 10, 2024

BUY
$85.37 - $115.44 $438 Million - $592 Million
5,129,800 Added 15.13%
39,036,872 $4.16 Billion
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $434 Million - $653 Million
6,248,623 Added 22.59%
33,907,072 $3.37 Billion
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $18.9 Million - $24.8 Million
196,012 Added 0.71%
27,658,449 $2.86 Billion
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $7.62 Million - $10.3 Million
-64,312 Reduced 0.23%
27,462,437 $3.34 Billion
Q1 2023

Jul 14, 2023

BUY
$135.66 - $197.02 $63,624 - $92,402
469 Added 0.0%
27,526,749 $4.23 Billion
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $33.1 Million - $48.1 Million
244,107 Added 0.89%
27,526,280 $4.23 Billion
Q4 2022

Feb 10, 2023

SELL
$118.38 - $210.04 $18.9 Million - $33.6 Million
-159,985 Reduced 0.58%
27,282,173 $4.9 Billion
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $24.4 Million - $40.1 Million
-206,299 Reduced 0.75%
27,442,158 $3.25 Billion
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $71.5 Million - $108 Million
610,265 Added 2.26%
27,648,457 $3.95 Billion
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $49.1 Million - $91.3 Million
-388,378 Reduced 1.42%
27,038,192 $4.66 Billion
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $55.4 Million - $90.3 Million
245,159 Added 0.9%
27,426,570 $6.97 Billion
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $1.55 Billion - $3.38 Billion
6,986,507 Added 34.6%
27,181,411 $10.5 Billion
Q2 2021

Aug 13, 2021

BUY
$129.91 - $234.98 $2.62 Billion - $4.75 Billion
20,194,904 New
20,194,904 $4.75 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.